Ex vivo and in vitro testis and ovary explants: Utility for identifying steroid biosynthesis inhibitors and comparison to a tier I screening battery

Toxicological Sciences

Volumn 46, Issue 1, 1998, Pages 61-74

  Powlin, S S ^a   Cook, J C ^a   Novak, S ^a   O'Connor, J C ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Ex vivo; Explants; In vitro; Ovary; Rat; Steroid biosynthesis inhibition; Testis

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTIANDROGEN; AROMATASE INHIBITOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ESTRADIOL; FINASTERIDE; FLUTAMIDE; FULVESTRANT; HALOPERIDOL; KETOCONAZOLE; RESERPINE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; ENDOCRINE DISEASE; EXPLANT; FEMALE; MALE; NONHUMAN; OVARY; RAT; STEROIDOGENESIS; TESTIS; TOXICITY TESTING;

ANIMALIA;

EID: 0032412395     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1998.2560     Document Type: Article

References (53)

1. G.T Ankley R.D Johnson G Toth L.C Fomar N.E Detenbeck S.P Bradbury Development of a research strategy for assessing the ecological risk of endocrine disruptors Rev. Toxicol. 1 1997 231 267
2. J Ashby E Houthoff S.J Kennedy J Stevens R Bars F.W Jekat P Campbell J Van Miller F.M Carpanini G.L.P Randall The challenge posed by endocrine-disrupting chemicals Environ. Health Perspect. 105 1997 164 169
3. E Berman J.W Laskey Altered steroidogenesis in whole-ovary and adrenal culture in cycling rats Reprod. Toxicol. 7 1993 349 358
4. L.B Biegel J.C Cook M.E Hurtt Isolation and primary culture of Leydig cells Methods in Reproductive Toxicology 1993 Academic Press New York p. 182–196
5. L.B Biegel R.C.M Liu M.E Hurtt J.C Cook Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, ex vivo Toxicol. Appl. Pharmacol. 134 1995 18 25
6. L.S Birnbaum Endocrine effects of prenatal exposure to PCB's dioxins, and other xenobiotics: Implications for policy and future research Environ. Health Perspect. 102 1994 676 679
7. J Bitman H.C Cecil Estrogenic activity of DDT analogs and polychlorinated biphenyls J. Agr. Food Chem. 18 1970 1108 1112
8. E.W Carney A.M Hoberman D.R Farmer R.W Kapp Jr. A.I Nikiforov M Bernstein M.E Hurtt W.J Breslin S.Z Cagen G.P Daston Estrogen modulation: Tiered testing for hazard evaluation Repro. Toxicol. 1997
9. J.H Clark B.M Markaverich The agonistic and antagonistic effects of short acting estrogens: A review Pharmacol. Ther. 21 1983 429 453
10. T Colborn D Dumanoski J.P Myers Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival? A Scientific Detective Story 1996 Dutton Books New York
11. T Colborn F.S vom Saal A.M Soto Developmental effects of endocrine-disrupting chemicals in wildlife and humans Environ. Health Perspect. 101 1993 378 384
12. J.C Cook A.M Kaplan L.G Davis J.C O'Connor Development of a tier I screening battery for detecting endocrine active compounds Regul. Toxicol. Pharmacol. 26 1997 60 68
13. J.C Cook L.S Mullin S.R Frame L.B Biegel Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats Toxicol. Appl. Pharmacol. 119 1993 195 204
14. Crisp, T. M. Clegg, E. D. Cooper, R. L. Anderson, D. G. Baetcke, K. P. Hoffmann, J. L. Morrow, M. S. Rodier, D. J. Schaeffer, J. E. Touart, L. W. Zeeman, M. G. Patel, Y. M. Wood, W. P. 1997, Special Report on Environmental Endocrine Disruption: An Effects Assessment and Analysis
15. M Dukes P.N Edwards M Large I.K Smith T Boyle The preclinical pharmacology of “arimidex” (anastrozole; ZD1033)—A potent, selective aromatase inhibitor J. Steroid Biochem. Mol. Biol. 58 1996 439 445
16. L.L Ewing B.R Zirkin Leydig cell structure and steroidogenic function Recent Prog. Horm. Res. 39 1983 599 635
17. D Feldman Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis Endoc. Rev. 7 1986 409 420
18. W.B Gill F.B Schumacher F.H Straus H.W Schoenberg Association of diethylstilbestrol exposure in utero J. Urol. 122 1979 36 39
19. Goodman Gilman J.G Hardman A G. Gilman L.E Limbird Goodman & Gilman's Pharmacologic Basis of Therapeutics 1996 McGraw–Hill New York
20. L.E Gray Jr. G Klinefelter W Kelce J Laskey J Ostby L Ewing Hamster Leydig cells are less sensitive to ethane dimethanesulfonate when compared to rat Leydig cells both in vivo in vitro. Toxicol. Appl. Pharmacol. 130 1995 248 256
21. L.E Gray Jr. W.R Kelce T Wiese R Tyl K Gaido J Cook G Klinefelter D Desaulniers E Wilson T Zacharewski C Waller P Foster J Laskey J Reel J Giesy S Laws J McLachlan W Breslin R Cooper R Di Giulio R Johnson R Purdy E Mihaich S Safe C Sonnenschein W Welshons R Miller S McMaster T Colborn Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms Reprod. Toxicol. 11 1997 719 750
22. A Herbst H Ulfelder D.C Poskanzer Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women N. Engl. J. Med. 284 1971 878 881
23. P Holmes C Humfrey M Scullion Appraisal of Test Methods for Sex-Hormone Disrupting Chemicals 1998 OECD Environment DirectorateEnvironmental Health and Safety Division Paris
24. J.B Hutchison C Beyer R.E Hutchison A Wozniak Sex differences in the regulation of embryonic brain aromatase J. Steroid Biochem. Mol. Biol. 61 1997 315 322
25. Environmental Oestrogens: Consequences to Human Health and Wildlife 1995 Institute for Environment and Health Norwich
26. P.B Kan M.A Hirst D Feldman Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs J. Steroid Biochem. 23 1985 1023 1029
27. R.J Kavlock G.P Daston C DeRosa P Fenner-Crisp L.E Gray S Kaattari G Lucier M Luster M.J Mac C Maczka R Miller J Moore R Rolland G Scott D.M Sheehan T Sinks H.A Tilsonj Research needs for the risk assessment of health and environmental effects of endocrine disrupters: A report of the U.S. EPA-sponsored workshop Environ. Health Perspect. 104 1996 715 740
28. G Klinefelter W.R Kelce Leydig cell responsiveness to hormonal and nonhormonal factors in vivo in vitro. A.H Payne M.P Hardy L.D Russell The Leydig Cell 1996 Cache River Press Vienna 535 553
29. J.W Laskey E Berman Steroidogenic assessment using ovary culture in cycling rats: Effects of bis(2-diethylhexyl)phthalate on ovarian steroid production Reprod. Toxicol. 7 1993 25 33
30. J.W Laskey E Berman J.M Ferrell The use of cultured ovarian fragments to assess toxicant alterations in steroidogenesis in the Sprague–Dawley rat Reprod. Toxicol. 9 1995 131 141
31. J.W Laskey G.R Klinefelter W.R Kelce L.L Ewing Effects of ethane dimethanesulfonate (EDS) on adult and immature rabbit Leydig cells: comparison with EDS-treated rat Leydig cells Biol. Reprod. 50 1994 1151 1160
32. D Lewis Physical methods in the study of the active site geometry of cytochromes P-450 Drug Metab. Rev. 17 1986 1 66
33. S.L.M.C Mendis-Handagama B.R Zirkin L.L Ewing Comparison of components of the testis interstitium with testosterone secretion in hamster, rat and guinea pig testes perfused in vitro. Am. J. Anat. 181 1988 12 22
34. R Neri K Florance P Koziol S.V Cleave A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4′-nitro-3′-trifluoromethylisobutyranilide) Endocrinology 91 1972 427 437
35. 17α Biochem. Biophys. Res. Commun. 154 1988 151 158
36. J.C O'Connor S.R Frame L.B Biegel J.C Cook L.G Davis Sensitivity of a Tier I screening battery compared to an in utero Toxicol. Sci. 44 1998 169 184
37. J.C O'Connor J.C Cook T.W Slone S.R Frame L.D Davis An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs) Toxicol. Sci. 46 1998 45 60
38. A.D Okonmah W.G Bradshaw P Coueyro K.F.A Soliman The effect of neuroleptic drugs on serum testosterone level in the male rat Gen. Pharmacol. 17 1986 235 238
39. Physicians' Desk Reference 1996 Medical Economics Data Oradell
40. M Piasek J.W Laskey Acute cadmium exposure and ovarian steroidogenesis in cycling and pregnant rats Reprod. Toxicol. 8 1994 495 507
41. A Pont P.L Williams S Azhar R.E Reitz C Bochra E.R Smith D.A Stevens Ketoconazole blocks testosterone synthesis Arch. Intern. Med. 142 1982 2137 2140
42. H.S Purba E.J King P Richert A.S Bhatnagar Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver J. Steroid Biochem. Mol. Biol. 48 1994 215 219
43. J Reel J Lamb B Neal Survey and assessment of mammalian estrogen biological assays for hazard characterization Fundam. Appl. Toxicol. 34 1996 288 305
44. P Rinieris J Hatzimanolis M Markianos C Stefanis Effects of treatment with various doses of haloperidol on the pituitary–gonadal axis in male schizophrenic patients Neuropsychobiology 22 1990 146 149
45. R.S Rittmaster Finasteride N. Engl. J. Med. 330 1994 120 125
46. S.H Safe Environmental and dietary estrogens and human health: Is there a problem Environ. Health Perspect. 103 1995 346 351
47. H.A Shalanick Basic studies on aminoglutethimide Cancer Res. 42 1982 3315s 3321s
48. M.D Shelby R.R Newbold D.B Tully K Chae V.L Davis Assessing environmental chemicals for estrogenicity using a combination of in vitro in vivo Environ. Health Perspect. 104 1996 1296 1300
49. J Simard I Luthy J Guay A Belanger F Labrie Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues Mol. Cell. Endocrinol. 44 1986 261 270
50. B.G Steinetz E.M O'Byrne W.K Sawyer M.C Butler J Munigle R.E Steele Effects of aminoglutethimide on cervical dilatability and serum immunoreactive relaxin in pregnant rats (41989) Proc. Soc. Exp. Biol. Med. 178 1985 101 104
51. C.H Tsai-Morris G Knox S Luna M.L Dufau Acquisition of estradiol-mediated regulatory mechanism of steroidogenesis in cultured fetal rat Leydig cell J. Biol. Chem. 261 1986 3471 3474
52. A.E Wakeling M Dukes J Bowler A potent specific pure antiestrogen with clinical potential Cancer Res. 51 1991 3867 3873
53. T.-Y Wing L.L Ewing B.R Zirkin Effect of LH withdrawal on Leydig cell smooth endoplasmic reticulum and steroidogenic reactions which convert pregnenolone to testosterone Endocrinology 115 1984 2290 2296